Largest biotechnology: pharmaceutical preparations companies
Every US-listed biotechnology: pharmaceutical preparations company we cover, 498 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$5.428 T
5.8% of all US-listed value
Companies
498
Ranked #5 of 152 industries
Average
$10.900 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.29T | $1,369.96 | -3.39% | United States |
| 2 | Johnson & JohnsonJNJ | $656.3B | $272.63 | -1.33% | United States |
| 3 | AbbVieABBV | $510.3B | $288.70 | -2.08% | United States |
| 4 | Merck & Co.MRK | $362.2B | $146.94 | -2.28% | United States |
| 5 | NovartisNVS | $309.0B | $161.93 | -1.85% | Switzerland |
| 6 | AstrazenecaAZN | $290.1B | $187.08 | -1.02% | United Kingdom |
| 7 | Abbott LaboratoriesABT | $197.0B | $113.74 | -1.53% | United States |
| 8 | Novo Nordisk A SNVO | $178.7B | $40.36 | -4.33% | Denmark |
| 9 | PfizerPFE | $170.5B | $29.91 | -2.87% | United States |
| 10 | Vertex PharmaceuticalsVRTX | $137.7B | $542.93 | -1.11% | United States |
| 11 | Bristol Myers SquibbBMY | $129.3B | $63.24 | -1.49% | United States |
| 12 | SanofiSNY | $114.3B | $46.87 | -1.27% | France |
| 13 | GSKGSK | $101.9B | $50.38 | -1.50% | United Kingdom |
| 14 | Regeneron PharmaceuticalsREGN | $93.4B | $902.98 | -2.98% | United States |
| 15 | Takeda PharmaceuticalTAK | $67.1B | $21.25 | +0.88% | Japan |
| 16 | Teva Pharmaceutical IndustriesTEVA | $48.7B | $41.77 | -0.20% | Israel |
| 17 | BeOne MedicinesONC | $44.0B | $387.35 | +2.53% | Cayman Islands |
| 18 | Royalty PharmaRPRX | $38.9B | $67.75 | +0.28% | United States |
| 19 | ZoetisZTS | $33.9B | $82.06 | -8.00% | United States |
| 20 | Genmab A/SGMAB | $33.0B | $52.86 | -4.10% | Denmark |
| 21 | Roivant SciencesROIV | $26.5B | $36.70 | -4.00% | United Kingdom |
| 22 | United TherapeuticsUTHR | $24.1B | $566.79 | -6.85% | United States |
| 23 | InsmedINSM | $23.9B | $108.76 | -1.13% | United States |
| 24 | ViatrisVTRS | $21.8B | $18.98 | -1.27% | United States |
| 25 | Alnylam PharmaceuticalsALNY | $21.0B | $156.95 | -2.57% | United States |
| 26 | Ascendis Pharma A/SASND | $16.7B | $253.39 | -1.76% | Denmark |
| 27 | Jazz PharmaceuticalsJAZZ | $14.6B | $227.19 | -3.18% | Ireland |
| 28 | BridgeBio PharmaBBIO | $14.5B | $74.31 | -4.60% | United States |
| 29 | Dr Reddys LaboratoriesRDY | $12.1B | $14.54 | -1.59% | India |
| 30 | Elanco Animal HealthELAN | $11.8B | $23.65 | -6.56% | United States |
| 31 | Summit TherapeuticsSMMT | $11.5B | $14.40 | -10.98% | United States |
| 32 | Biomarin PharmaceuticalBMRN | $10.9B | $56.26 | -1.52% | United States |
| 33 | Madrigal PharmaceuticalsMDGL | $9.30B | $400.30 | -0.03% | United States |
| 34 | Spyre TherapeuticsSYRE | $9.21B | $96.94 | -2.12% | United States |
| 35 | Tg TherapeuticsTGTX | $8.87B | $57.98 | -5.92% | United States |
| 36 | Protagonist TherapeuticsPTGX | $8.76B | $135.31 | -5.62% | United States |
| 37 | Arrowhead PharmaceuticalsARWR | $8.11B | $57.44 | -6.83% | United States |
| 38 | Corcept TherapeuticsCORT | $7.86B | $71.82 | -9.35% | United States |
| 39 | CytokineticsCYTK | $7.74B | $55.58 | -12.61% | United States |
| 40 | AlkermesALKS | $7.50B | $44.63 | -2.75% | Ireland |
| 41 | AbivaxABVX | $7.35B | $84.25 | -5.86% | France |
| 42 | Praxis Precision MedicinesPRAX | $7.34B | $263.01 | -7.65% | United States |
| 43 | Rhythm PharmaceuticalsRYTM | $7.21B | $104.00 | -6.04% | United States |
| 44 | Kiniksa Pharmaceuticals InternationalKNSA | $6.95B | $88.42 | -8.01% | United States |
| 45 | Axsome TherapeuticsAXSM | $6.80B | $129.28 | -5.63% | United States |
| 46 | Amneal PharmaceuticalsAMRX | $6.78B | $19.46 | -2.48% | United States |
| 47 | Ionis PharmaceuticalsIONS | $6.43B | $38.70 | -3.61% | United States |
| 48 | Mirum PharmaceuticalsMIRM | $6.11B | $93.62 | -3.45% | United States |
| 49 | Ligand PharmaceuticalsLGND | $5.95B | $297.63 | -5.85% | United States |
| 50 | GrifolsGRFS | $5.85B | $8.51 | -1.22% | Spain |
| 51 | Belite BioBLTE | $5.76B | $142.93 | -7.20% | United States |
| 52 | Ptc TherapeuticsPTCT | $5.48B | $65.56 | -4.94% | United States |
| 53 | VeradermicsMANE | $5.38B | $128.74 | -5.69% | United States |
| 54 | Cogent BiosciencesCOGT | $5.14B | $29.61 | -5.97% | United States |
| 55 | Travere TherapeuticsTVTX | $4.70B | $49.00 | -6.52% | United States |
| 56 | Dianthus TherapeuticsDNTH | $4.69B | $83.30 | -2.92% | United States |
| 57 | ErascaERAS | $4.64B | $13.27 | -11.03% | United States |
| 58 | Legend BiotechLEGN | $4.39B | $22.56 | -0.94% | United States |
| 59 | Edgewise TherapeuticsEWTX | $4.26B | $38.87 | +3.57% | United States |
| 60 | LiquidiaLQDA | $3.98B | $44.49 | -6.10% | United States |
| 61 | Xenon PharmaceuticalsXENE | $3.66B | $37.76 | -3.65% | Canada |
| 62 | Acadia PharmaceuticalsACAD | $3.65B | $21.20 | -1.26% | United States |
| 63 | Organon & Co.OGN | $3.63B | $13.81 | -0.14% | United States |
| 64 | AbCellera BiologicsABCL | $3.60B | $11.12 | -9.45% | Canada |
| 65 | Tango TherapeuticsTNGX | $3.52B | $20.91 | -9.81% | United States |
| 66 | Disc MedicineIRON | $3.49B | $78.71 | -5.49% | United States |
| 67 | Amylyx PharmaceuticalsAMLX | $3.48B | $27.75 | -5.61% | United States |
| 68 | Arcutis BiotherapeuticsARQT | $3.42B | $27.01 | -20.68% | United States |
| 69 | Parabilis MedicinesPBLS | $3.41B | $27.94 | -7.97% | United States |
| 70 | Viking TherapeuticsVKTX | $3.29B | $25.80 | -7.78% | United States |
| 71 | Enliven TherapeuticsELVN | $3.28B | $44.73 | -5.33% | United States |
| 72 | Dyne TherapeuticsDYN | $3.25B | $17.38 | -6.26% | United States |
| 73 | Viridian TherapeuticsVRDN | $3.24B | $28.54 | -1.77% | United States |
| 74 | Telix PharmaceuticalsTLX | $3.19B | $9.43 | -2.48% | Australia |
| 75 | Bausch Health CompaniesBHC | $2.99B | $7.99 | -4.26% | Canada |
| 76 | IDEAYA BiosciencesIDYA | $2.97B | $30.67 | -5.22% | United States |
| 77 | Vicore Pharma Holding ABVCRE | $2.95B | $10.49 | +9.84% | Sweden |
| 78 | XencorXNCR | $2.56B | $34.10 | -2.67% | United States |
| 79 | Arcus BiosciencesRCUS | $2.55B | $17.74 | -8.13% | United States |
| 80 | Zai LabZLAB | $2.54B | $22.62 | -0.79% | China |
| 81 | HUTCHMED (China)HCM | $2.48B | $14.20 | +2.01% | Hong Kong |
| 82 | Palvella TherapeuticsPVLA | $2.48B | $156.26 | -3.71% | United States |
| 83 | Xeris BiopharmaXERS | $2.37B | $13.00 | +24.29% | United States |
| 84 | MBX BiosciencesMBX | $2.34B | $48.59 | -7.41% | United States |
| 85 | PharvarisPHVS | $2.28B | $32.70 | -4.75% | Netherlands |
| 86 | NewAmsterdam PharmaNAMS | $2.27B | $18.90 | -9.72% | Netherlands |
| 87 | SepternaSEPN | $2.22B | $47.51 | -0.77% | United States |
| 88 | Lakefront BiotherapeuticsLKFT | $2.22B | $33.65 | -1.29% | Belgium |
| 89 | PERRIGOPRGO | $2.18B | $15.72 | -0.73% | United States |
| 90 | Vera TherapeuticsVERA | $2.17B | $30.18 | -5.60% | United States |
| 91 | Aurinia PharmaceuticalsAUPH | $2.17B | $16.21 | -5.29% | Canada |
| 92 | SchrodingerSDGR | $2.16B | $28.82 | +1.05% | United States |
| 93 | ImmunomeIMNM | $2.13B | $18.04 | -7.61% | United States |
| 94 | Prestige Consumer HealthcarePBH | $2.11B | $44.57 | -16.36% | United States |
| 95 | BiohavenBHVN | $2.09B | $13.85 | -9.15% | United States |
| 96 | ZymeworksZYME | $2.03B | $28.83 | -6.84% | United States |
| 97 | First Tracks BiotherapeuticsTRAX | $1.92B | $45.58 | -7.05% | United States |
| 98 | Harmony BiosciencesHRMY | $1.91B | $32.51 | -5.54% | United States |
| 99 | Sarepta TherapeuticsSRPT | $1.85B | $17.51 | -7.79% | United States |
| 100 | Trevi TherapeuticsTRVI | $1.84B | $12.93 | -7.58% | United States |
Showing 1–100 of 498 companies. One row per company, with secondary share classes folded into their primary listing.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 100Computer Software: Prepackaged Software 232Computer Software: Programming Data Processing 77Computer Manufacturing 10Major Banks 244Catalog/Specialty Distribution 30Industrial Machinery/Components 210Business Services 90Commercial Banks 35Auto Manufacturing 29Integrated oil Companies 16Department/Specialty Retail Stores 13Real Estate Investment Trusts 173Investment Bankers/Brokers/Service 69Oil & Gas Production 116Beverages (Production/Distribution) 36Telecommunications Equipment 84Electric Utilities: Central 61Finance: Consumer Services 164Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 44Consumer Electronics/Appliances 23Property-Casualty Insurers 68Natural Gas Distribution 27All industries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.